Natera, Inc.
NTRA
Cena:
$ 203.19
-0.50 (-0.25%)
Valuace
100
Růst
70
Zdraví
71
Akcionáři
Akcionáři společnosti
Insider trading
Akcionáři společnosti
| Držitel | Počet akcií | Podíl společnosti | Změna % | Váha pozice v portfoliu | Prvně nakoupeno |
|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | 13.4 mil | 9.79% | -0.02% | 0.16% | 2017-12-31 |
| VANGUARD GROUP INC | 12.3 mil | 8.97% | 0.01% | 0.04% | 2015-09-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 12.2 mil | 8.91% | 0.01% | 0.28% | 2018-09-30 |
| BLACKROCK, INC. | 10.7 mil | 7.81% | 0.00% | 0.04% | 2024-09-30 |
| BLACKROCK FUNDING, INC. /DE | 9.2 mil | 7.42% | 0.01% | 0.03% | 2024-09-30 |
| BLACKROCK INC. | 6.8 mil | 5.60% | 0.00% | 0.02% | 2015-09-30 |
| 5.6 mil | 4.13% | 0.06% | 0.06% | 2026-03-31 | |
| WELLINGTON MANAGEMENT GROUP LLP | 4.8 mil | 3.49% | -0.02% | 0.18% | 2024-06-30 |
| STATE STREET CORP | 3.4 mil | 2.50% | 0.00% | 0.02% | 2015-09-30 |
| FARALLON CAPITAL MANAGEMENT LLC | 3.2 mil | 2.35% | -0.41% | 3.66% | 2021-06-30 |
| DUQUESNE FAMILY OFFICE LLC | 3.1 mil | 2.24% | 5.34% | 18.14% | 2022-09-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.8 mil | 2.03% | 0.00% | 0.03% | 2015-09-30 |
| FMR LLC | 2.6 mil | 1.87% | 0.01% | 0.03% | 2018-09-30 |
| COATUE MANAGEMENT LLC | 2.5 mil | 1.86% | 0.24% | 1.75% | 2025-09-30 |
| CASTLE HOOK PARTNERS LP | 2.5 mil | 1.85% | 0.10% | 2.16% | 2024-03-31 |
| FRANKLIN RESOURCES INC | 2.5 mil | 1.82% | -0.02% | 0.12% | 2023-03-31 |
| AQR CAPITAL MANAGEMENT LLC | 2.3 mil | 1.66% | -0.11% | 0.20% | 2023-06-30 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.0 mil | 1.49% | -0.01% | 0.14% | 2023-12-31 |
| FRED ALGER MANAGEMENT, LLC | 1.8 mil | 1.28% | -0.09% | 1.54% | 2018-06-30 |
| NORGES BANK | 1.6 mil | 1.18% | 0.04% | 0.04% | 2025-12-31 |
| SOFINNOVA INVESTMENTS, INC. | 1.6 mil | 1.13% | -3.53% | 11.78% | 2018-03-31 |
| CAPITAL WORLD INVESTORS | 1.5 mil | 1.07% | 0.00% | 0.04% | 2015-09-30 |
| MORGAN STANLEY | 1.4 mil | 0.99% | 0.00% | 0.02% | 2015-09-30 |
| INVESCO LTD. | 1.3 mil | 0.92% | -0.01% | 0.04% | 2019-03-31 |
| RTW INVESTMENTS, LP | 1.3 mil | 0.91% | -0.95% | 2.49% | 2019-09-30 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.2 mil | 0.87% | -0.03% | 0.13% | 2024-06-30 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.2 mil | 0.87% | -5.05% | 13.87% | 2022-03-31 |
| MAVERICK CAPITAL LTD | 1.2 mil | 0.86% | 0.38% | 2.70% | 2024-03-31 |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 1.1 mil | 0.83% | 0.08% | 0.16% | 2025-09-30 |
| LORD, ABBETT & CO. LLC | 1.1 mil | 0.81% | -0.13% | 0.73% | 2019-09-30 |
| FEDERATED HERMES, INC. | 1.1 mil | 0.80% | -0.04% | 0.35% | 2019-06-30 |
| MARSHALL WACE, LLP | 958.38 tis | 0.79% | 0.05% | 0.14% | 2020-12-31 |
| AMERIPRISE FINANCIAL INC | 934.97 tis | 0.69% | -0.02% | 0.04% | 2018-06-30 |
| CITADEL ADVISORS LLC | 896.67 tis | 0.66% | 0.00% | 0.02% | 2016-09-30 |
| CLEARBRIDGE INVESTMENTS, LLC | 893.32 tis | 0.65% | 0.01% | 0.16% | 2024-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 872.64 tis | 0.64% | 0.04% | 0.04% | 2026-03-31 |
| PERCEPTIVE ADVISORS LLC | 757.23 tis | 0.63% | 0.02% | 1.21% | 2022-09-30 |
| CREDIT SUISSE AG/ | 755.90 tis | 0.63% | 0.01% | 0.07% | 2016-06-30 |
| JENNISON ASSOCIATES LLC | 764.06 tis | 0.62% | 0.01% | 0.07% | 2023-12-31 |
| QUBE RESEARCH & TECHNOLOGIES LTD | 740.37 tis | 0.60% | 0.09% | 0.15% | 2023-03-31 |
| ALLIANCEBERNSTEIN L.P. | 792.41 tis | 0.59% | 0.00% | 0.04% | 2016-06-30 |
| SAMLYN CAPITAL, LLC | 718.35 tis | 0.58% | -1.23% | 1.38% | 2022-03-31 |
| NORTHERN TRUST CORP | 788.45 tis | 0.58% | 0.00% | 0.02% | 2015-09-30 |
| GOLDMAN SACHS GROUP INC | 767.23 tis | 0.56% | 0.00% | 0.02% | 2015-09-30 |
| NWI MANAGEMENT LP | 762.60 tis | 0.56% | 0.63% | 8.67% | 2024-06-30 |
| GILDER GAGNON HOWE & CO LLC | 755.28 tis | 0.55% | -0.19% | 1.81% | 2019-09-30 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 754.73 tis | 0.55% | -0.05% | 0.63% | 2024-12-31 |
| UBS ASSET MANAGEMENT AMERICAS INC | 752.94 tis | 0.55% | 0.00% | 0.03% | 2018-09-30 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 656.71 tis | 0.55% | 3.76% | 4.60% | 2023-12-31 |
| POINTSTATE CAPITAL LP | 739.88 tis | 0.54% | -0.54% | 1.87% | 2024-06-30 |
| BANK OF AMERICA CORP /DE/ | 733.67 tis | 0.54% | 0.00% | 0.01% | 2015-09-30 |
| EAGLE ASSET MANAGEMENT INC | 662.38 tis | 0.54% | 0.03% | 0.45% | 2024-06-30 |
| VOYA INVESTMENT MANAGEMENT LLC | 661.11 tis | 0.53% | -0.01% | 0.09% | 2016-06-30 |
| EAGLE HEALTH INVESTMENTS LP | 632.71 tis | 0.53% | 1.96% | 10.75% | 2020-12-31 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 712.75 tis | 0.52% | 0.00% | 0.02% | 2015-09-30 |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 692.37 tis | 0.51% | -0.01% | 0.09% | 2024-03-31 |
| ARK INVESTMENT MANAGEMENT LLC | 684.26 tis | 0.50% | -0.05% | 1.06% | 2024-03-31 |
| PICTET ASSET MANAGEMENT HOLDING SA | 586.77 tis | 0.49% | 0.00% | 0.06% | 2023-09-30 |
| BANK OF NEW YORK MELLON CORP | 669.72 tis | 0.49% | 0.00% | 0.02% | 2015-09-30 |
| NUVEEN ASSET MANAGEMENT, LLC | 583.12 tis | 0.47% | 0.01% | 0.03% | 2018-09-30 |
| POINT72 ASSET MANAGEMENT, L.P. | 624.78 tis | 0.46% | 0.10% | 0.20% | 2018-09-30 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 625.91 tis | 0.46% | 0.30% | 0.97% | 2022-09-30 |
| AVIDITY PARTNERS MANAGEMENT LP | 556.40 tis | 0.45% | 0.08% | 3.60% | 2020-09-30 |
| AMUNDI | 532.58 tis | 0.45% | 0.00% | 0.02% | 2021-06-30 |
| RAYMOND JAMES FINANCIAL INC | 591.04 tis | 0.43% | -0.01% | 0.03% | 2024-12-31 |
| CHEVY CHASE TRUST HOLDINGS, LLC | 587.03 tis | 0.43% | -0.02% | 0.34% | 2024-03-31 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 568.76 tis | 0.42% | -0.15% | 2.07% | 2024-03-31 |
| HOLOCENE ADVISORS, LP | 572.83 tis | 0.42% | 0.13% | 0.24% | 2025-03-31 |
| BLUE WATER LIFE SCIENCE ADVISORS, LP | 503.09 tis | 0.42% | 9.70% | 52.98% | 2020-12-31 |
| NINETY ONE UK LTD | 562.99 tis | 0.41% | 0.13% | 0.22% | 2025-03-31 |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 485.77 tis | 0.40% | 0.18% | 1.13% | 2023-03-31 |
| MILLENNIUM MANAGEMENT LLC | 527.94 tis | 0.39% | 0.02% | 0.04% | 2015-09-30 |
| FIRST TRUST ADVISORS LP | 528.80 tis | 0.39% | 0.02% | 0.08% | 2019-12-31 |
| EVERSEPT PARTNERS, LP | 519.64 tis | 0.38% | -6.61% | 5.76% | 2021-03-31 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 521.75 tis | 0.38% | 0.74% | 1.27% | 2019-06-30 |
| VICTORY CAPITAL MANAGEMENT INC | 515.24 tis | 0.38% | -0.01% | 0.07% | 2019-09-30 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 443.44 tis | 0.37% | -0.01% | 0.05% | 2020-06-30 |
| LEGAL & GENERAL GROUP PLC | 498.14 tis | 0.36% | 0.00% | 0.02% | 2016-06-30 |
| AMERICAN CENTURY COMPANIES INC | 496.90 tis | 0.36% | -0.01% | 0.05% | 2019-06-30 |
| D. E. SHAW & CO., INC. | 491.34 tis | 0.36% | -0.01% | 0.06% | 2020-03-31 |
| AGF MANAGEMENT LTD | 491.26 tis | 0.36% | -0.03% | 0.44% | 2024-03-31 |
| NUVEEN, LLC | 474.61 tis | 0.35% | 0.00% | 0.03% | 2025-03-31 |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 471.08 tis | 0.34% | 0.27% | 1.25% | 2024-03-31 |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 463.48 tis | 0.34% | -0.01% | 0.16% | 2021-12-31 |
| ASSENAGON ASSET MANAGEMENT S.A. | 406.65 tis | 0.34% | 0.08% | 0.10% | 2020-03-31 |
| PRINCIPAL FINANCIAL GROUP INC | 429.33 tis | 0.31% | -0.02% | 0.03% | 2015-09-30 |
| ORBIMED ADVISORS LLC | 429.30 tis | 0.31% | -0.88% | 1.63% | 2015-09-30 |
| SEI INVESTMENTS CO | 354.86 tis | 0.29% | 0.01% | 0.05% | 2018-06-30 |
| C WORLDWIDE GROUP HOLDING A/S | 330.00 tis | 0.27% | -0.07% | 0.39% | 2023-03-31 |
| LOOMIS SAYLES & CO L P | 323.87 tis | 0.27% | -0.02% | 0.05% | 2023-03-31 |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 307.72 tis | 0.26% | 0.03% | 0.05% | 2019-09-30 |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 296.73 tis | 0.25% | 0.03% | 0.13% | 2019-12-31 |
Insider trading
| Jméno | Pozice | Typ transakce | Počet převedených akcií | Průměrná cena akcie | Datum | Počet držených akcií |
|---|---|---|---|---|---|---|
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 9 | 203.30 | 15.5 2026 | 19532 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 30 | 202.84 | 15.5 2026 | 19532 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 285 | 202.68 | 15.5 2026 | 19541 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 290 | 202.58 | 15.5 2026 | 19562 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 360 | 201.19 | 15.5 2026 | 19826 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 345 | 201.11 | 15.5 2026 | 19852 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 96 | 199.43 | 15.5 2026 | 20186 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 85 | 199.52 | 15.5 2026 | 20197 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 1150 | 210.35 | 15.5 2026 | 252502 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 200 | 209.57 | 15.5 2026 | 253652 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 700 | 208.13 | 15.5 2026 | 253852 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 900 | 207.24 | 15.5 2026 | 254552 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 200 | 205.43 | 15.5 2026 | 255452 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 1697 | 206.77 | 6.5 2026 | 2376402 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 948 | 205.22 | 6.5 2026 | 2377843 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 1454 | 241.39 | 6.5 2026 | 2378099 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | A-Award | 2389 | 0.00 | 6.5 2026 | 2378791 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 2887 | 206.77 | 6.5 2026 | 2379553 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 722 | 206.16 | 6.5 2026 | 2382440 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 330 | 206.16 | 5.5 2026 | 222694 |
| Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | S-Sale | 902 | 206.16 | 5.5 2026 | 149867 |
| Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | S-Sale | 291 | 206.16 | 5.5 2026 | 187220 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 150 | 206.93 | 5.5 2026 | 142295 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 400 | 205.31 | 5.5 2026 | 142445 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 865 | 204.47 | 5.5 2026 | 142845 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 505 | 203.32 | 5.5 2026 | 143710 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 520 | 201.60 | 5.5 2026 | 144215 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 560 | 200.95 | 5.5 2026 | 144735 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 405 | 206.16 | 5.5 2026 | 145295 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 107 | 206.16 | 5.5 2026 | 255652 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 482 | 210.49 | 5.5 2026 | 57496 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 313 | 206.16 | 5.5 2026 | 57978 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 805 | 196.99 | 29.4 2026 | 255711 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 2266 | 196.22 | 29.4 2026 | 256516 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 188 | 204.39 | 29.4 2026 | 258782 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 285 | 203.75 | 29.4 2026 | 258970 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 988 | 204.39 | 29.4 2026 | 223024 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 873 | 203.75 | 29.4 2026 | 224012 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 1185 | 204.39 | 29.4 2026 | 145700 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 997 | 203.75 | 29.4 2026 | 146885 |
| Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | S-Sale | 917 | 204.39 | 29.4 2026 | 187511 |
| Fesko John | officer: PRESIDENT, CHIEF BUS. OFFICER | S-Sale | 771 | 203.75 | 29.4 2026 | 188428 |
| Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | S-Sale | 3566 | 204.39 | 29.4 2026 | 150769 |
| Chapman Steven Leonard | director, officer: CEO AND PRESIDENT | S-Sale | 2272 | 203.75 | 29.4 2026 | 154335 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 200 | 197.26 | 29.4 2026 | 58291 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 1070 | 194.82 | 29.4 2026 | 58491 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 1000 | 193.78 | 29.4 2026 | 59561 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 500 | 192.13 | 29.4 2026 | 60561 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 300 | 190.12 | 29.4 2026 | 61061 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 1222 | 204.39 | 29.4 2026 | 61361 |
| Brophy Michael Burkes | officer: CHIEF FINANCIAL OFFICER | S-Sale | 771 | 203.75 | 29.4 2026 | 62583 |
| Baynes Roy D. | director | A-Award | 83 | 0.00 | 28.4 2026 | 18512 |
| Bertagnolli Monica | director | A-Award | 83 | 0.00 | 28.4 2026 | 5374 |
| Williams Brinkley Ruth | director | A-Award | 86 | 0.00 | 28.4 2026 | 5475 |
| Rubin Eric H | director | A-Award | 5 | 0.00 | 28.4 2026 | 5 |
| BOTHA ROELOF | director | A-Award | 132 | 0.00 | 28.4 2026 | 2672 |
| BOTHA ROELOF | director | A-Award | 222 | 0.00 | 28.4 2026 | 2894 |
| Chapman Rowan E | director | A-Award | 114 | 0.00 | 28.4 2026 | 5866 |
| Chapman Rowan E | director | A-Award | 222 | 0.00 | 28.4 2026 | 6088 |
| Marcus Gail Boxer | director | A-Award | 108 | 0.00 | 28.4 2026 | 5961 |
| Marcus Gail Boxer | director | A-Award | 222 | 0.00 | 28.4 2026 | 6183 |
| ROSENMAN HERM | director | A-Award | 117 | 0.00 | 28.4 2026 | 20558 |
| ROSENMAN HERM | director | A-Award | 222 | 0.00 | 28.4 2026 | 20780 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 750 | 199.59 | 21.4 2026 | 20282 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 750 | 199.66 | 21.4 2026 | 20282 |
| Rubin Eric H | 0 | 0.00 | 9.4 2026 | 0 | ||
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 58292 | 9.59 | 8.4 2026 | 0 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | F-InKind | 27610 | 204.87 | 8.4 2026 | 2383162 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 58292 | 9.59 | 8.4 2026 | 2410772 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 952 | 203.31 | 3.4 2026 | 147882 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 1000 | 202.36 | 3.4 2026 | 148834 |
| Moshkevich Solomon | officer: PRESIDENT, CLINICALDIAGNOSTICS | S-Sale | 1048 | 201.32 | 3.4 2026 | 149834 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 1909 | 205.00 | 3.4 2026 | 224885 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 1200 | 203.83 | 3.4 2026 | 226794 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 3213 | 203.07 | 3.4 2026 | 227994 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 1778 | 202.01 | 3.4 2026 | 231207 |
| RABINOWITZ DANIEL | officer: SEC. AND CHIEF LEGAL OFFICER | S-Sale | 300 | 200.79 | 3.4 2026 | 232985 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 41708 | 9.59 | 1.4 2026 | 58292 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 41708 | 9.59 | 1.4 2026 | 2352480 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 371 | 200.97 | 20.3 2026 | 21032 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 280 | 200.90 | 20.3 2026 | 21032 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 235 | 199.88 | 20.3 2026 | 21312 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 140 | 199.82 | 20.3 2026 | 21403 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 239 | 198.85 | 20.3 2026 | 21543 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 235 | 198.49 | 20.3 2026 | 21547 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 1814 | 198.65 | 20.3 2026 | 259255 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 956 | 197.84 | 20.3 2026 | 261069 |
| Sheena Jonathan | director, other: CO-FOUNDER | S-Sale | 300 | 196.27 | 20.3 2026 | 262025 |
| Chapman Rowan E | director | S-Sale | 122 | 191.38 | 17.3 2026 | 5752 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 2300 | 194.17 | 16.3 2026 | 2357172 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 900 | 192.43 | 16.3 2026 | 2359472 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 300 | 190.68 | 16.3 2026 | 2360372 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 100 | 190.07 | 16.3 2026 | 2360672 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 50000 | 9.59 | 16.3 2026 | 2360772 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 2886 | 189.64 | 16.3 2026 | 2362535 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 6451 | 188.52 | 16.3 2026 | 2365421 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 17037 | 187.63 | 16.3 2026 | 2368735 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 5809 | 187.52 | 16.3 2026 | 2371872 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | S-Sale | 8091 | 186.75 | 16.3 2026 | 2377681 |
| Rabinowitz Matthew | director, officer: EXECUTIVE CHAIRMAN | M-Exempt | 75000 | 9.59 | 16.3 2026 | 2385772 |
